Int J Health Policy Manag. 2022;11(12): 3101-3113. doi: 10.34172/ijhpm.2022.6942

PMID: 36028975 PMCID: PMC10105197

Original Article

More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap

Luciana Correia Borges ¹ , Henrique Zeferino de Menezes ² , Eric Crosbie ^1,3 *

Cited by CrossRef:

1- Bell D, Brown G, Oyibo W, Ouédraogo S, Tacheva B, Barbaud E, Kalk A, Ridde V, Paul E. COVAX – Time to reconsider the strategy and its target. Health Policy OPEN. 2023;4:100096 [Crossref]

2- Ortiz-Millán G. Ethical and Practical Considerations for an Agreement to Ensure Equitable Vaccine Access Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap". Int J Health Policy Manag. 2024;13:8516 [Crossref]

3- Kumar Chattu V, Pushkaran A, Narayanan P. Political Prioritization of Access to Medicines and Right to Health: Need for an Effective Global Health Governance Through Global Health Diplomacy Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap". Int J Health Policy Manag. 2024;13:8578 [Crossref]

4- Lexchin J. Profits First, Health Second: The Pharmaceutical Industry and the Global South Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap". Int J Health Policy Manag. 2024;13:8471 [Crossref]

Submit Your Paper Archive